Stockscreener 앱 받기
54.04
0.52%
0.28
시장 영업 전:
54.96
0.92
+1.70%
Azenta Inc 주식(AZTA)의 최신 뉴스
Azenta, Inc. Shows Positive Outlook in Earnings Call - TipRanks
Conestoga Capital Advisors LLC Increases Stock Position in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Azenta (NASDAQ:AZTA) Posts Quarterly Earnings Results, Beats Expectations By $0.03 EPS - MarketBeat
Azenta stock price target raised to $52 at Jefferies - MSN
Azenta Inc (AZTA) expanding its growth trajectory ahead - SETE News
A Glimpse Into The Expert Outlook On Azenta Through 4 Analysts - Benzinga
Long AZTA: Azenta Inc. Rebounds from $50 Support, Eyes $60 Target Amid Positive Q1 Results - Invezz
Azenta Inc (AZTA) Q1 2025 Earnings Call Highlights: Strong Revenue Growth Amid Strategic Challenges - Yahoo Canada Finance
Azenta, Inc. Reports Strong Q1 2025 Results - TipRanks
The Attractiveness of Investing In Azenta Inc (AZTA) is Growing - Knox Daily
Azenta reiterates 2025 guidance with 3-5% organic growth and EBITDA margin expansion - MSN
Azenta stock price target raised to $59 at Needham - Investing.com
Azenta Reports First Quarter Results for Fiscal 2025, Ended December 31, 2024 - The Malaysian Reserve
Brooks: Fiscal Q1 Earnings Snapshot -February 05, 2025 at 07:30 am EST - Marketscreener.com
Azenta’s (NASDAQ:AZTA) Q4 Sales Top Estimates - Yahoo Finance
Azenta Inc Reiterates FY 2025 Revenue Guidance Of 3% To 5% Organic Growth -February 05, 2025 at 07:38 am EST - Marketscreener.com
Earnings Flash (AZTA) AZENTA Reports Q1 Adjusted EPS $0.08, vs. FactSet Est of $0.10 - Marketscreener.com
Azenta, Inc. (NASDAQ:AZTA) Short Interest Update - MarketBeat
Is Azenta (AZTA) the Mid-Cap Stock Insiders Are Buying Recently? - Insider Monkey
Loss-making Azenta (NASDAQ:AZTA) sheds a further US$110m, taking total shareholder losses to 40% over 3 years - Simply Wall St
Azenta eyes streamlined focus, plans B Medical segment sale - MSN
16,253 Shares in Azenta, Inc. (NASDAQ:AZTA) Bought by SG Americas Securities LLC - MarketBeat
Azenta Inc (AZTA) Reports Q4 Revenue of $150.83M, EPS of -$0.11, Surpassing Estimates - GuruFocus.com
Revolutionizing Biotech: Dipal Doshi Joins Azenta's Board of Directors! - Clinique Bio
Azenta eyes streamlined focus, plans B Medical segment sale By Investing.com - Investing.com Australia
Azenta elects Entrada CEO to Board of Directors - MSN
Azenta elects Entrada CEO to Board of Directors By Investing.com - Investing.com Canada
Azenta Announces the Election of Dipal Doshi to its Board of Directors - StreetInsider.com
Rising Biotech Leader Joins Azenta Board: Strategic Move Signals Growth Ambitions - StockTitan
SG Americas Securities LLC Makes New Investment in Azenta, Inc. (NASDAQ:AZTA) - Defense World
Azenta (AZTA) Projected to Post Quarterly Earnings on Wednesday - Defense World
Azenta Announces Fiscal 2025 First Quarter Earnings Conference Call and Webcast - BioSpace
Azenta: Taking A Pass (NASDAQ:AZTA) - Seeking Alpha
Azenta, Inc. (NASDAQ:AZTA) Stock Position Cut by Park Avenue Securities LLC - Defense World
4,003 Shares in Azenta, Inc. (NASDAQ:AZTA) Bought by Assenagon Asset Management S.A. - Defense World
Exchange Traded Concepts LLC Boosts Stock Holdings in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
UK Biocentre Selects the Azenta Life Sciences BioArc Ultra Automated Storage System to Advance Research Excellence - PR Newswire
PR News Wire SpaceDaily.com Widget Page - Space Daily
Azenta Wins Major UK Biocentre Contract for 16M-Sample Storage System Expansion - StockTitan
Bullish Azenta Insiders Loaded Up On US$1.29m Of Stock - Yahoo Finance
Oak Thistle LLC Acquires New Shares in Azenta, Inc. (NASDAQ:AZTA) - MarketBeat
Clinical-grade long-read sequencing test gains US regulatory approval - Labmate Online
GAMMA Investing LLC Sells 334 Shares of Azenta, Inc. (NASDAQ:AZTA) - Defense World
At US$51.81, Is Azenta, Inc. (NASDAQ:AZTA) Worth Looking At Closely? - Simply Wall St
Azenta (NASDAQ:AZTA) Given Overweight Rating at Stephens - Defense World
Azenta's (AZTA) "Overweight" Rating Reiterated at Stephens - MarketBeat
10.10%
0.93%
자본화:
|
볼륨(24시간):